市场调查报告书
商品编码
1276433
医用辐射探测器全球市场规模、份额和行业趋势分析报告:按产品、类型、最终用途、区域展望和预测,2023-2029 年Global Medical Radiation Detection Market Size, Share & Industry Trends Analysis Report By Product, By Type (Gas-filled Detectors, Scintillators and Solid-state), By End-Use, By Regional Outlook and Forecast, 2023 - 2029 |
预计到 2029 年,医用辐射检测仪市场规模将达到 15 亿美元,预测期内復合年增长率为 7.7%。
随着世界各地建造更多的核电站,对辐射监测技术的需求也越来越大。这些电厂产品类别可以应用于医疗保健领域。医院还支持使用提供给患者的医用同位素建造诊断成像设备。
来自人造辐射源的大部分人体剂量是由于诊断放射照相术以及在肿瘤学和其他重要疾病中使用放射性同位素进行的治疗。此外,未来还计划使用使用放射性元素的诊断和治疗技术。放射(放射性同位素)疗法仍然是用于治疗癌症的主要方法之一。供应商提供用于个人剂量管理的个人剂量计和自动化系统,以减少辐射对医疗机构工作人员的有害影响。製造商和研究人员将创新技术融入到他们的产品中,以保持他们的市场领导地位。
COVID-19 影响分析
大流行改变了诊断成像测试的执行方式。许多医疗机构已实施新政策以降低 COVID-19 传播的风险,例如采用便携式 X 光机和减少扫瞄期间房间内的医务人员数量。这些变化增加了对可在各种情况下使用的移动和手持式医疗辐射检测工具的需求。考虑到这些因素,可以说医用辐射检测仪市场大大受益于 COVID-19 的传播。
市场增长因素
全球癌症患者增加
近年来,各种癌症的治疗、检测和预防取得了显着进展。手术、化学疗法、放射疗法、生物疗法和激素疗法用于治疗癌症。阿霉素是一种常用的化疗药物,用于治疗多种类型的肿瘤。氧化应激会影响肾臟、心臟和大脑。转移性乳腺癌的化疗耐药性仍然是有效治疗的一个问题。因此,这一因素推动了医疗辐射探测器市场。
扩大放射治疗和核医学的应用
设备、IT 和核医学程序在过去十年中发生了巨大变化。使用核医学诊断和治疗癌症和心血管疾病等多种疾病增加了对辐射检测、监测和安全系统的需求。核医学中使用的检测器有多种类型,包括充气检测器、闪烁检测器和半导体检测器。考虑到这些因素,放射治疗和核医学的使用增加预计将支持市场的扩大。
市场製约因素
严格的监管义务
核管理委员会(NRC)、美国国家辐射防护委员会(NCRP)、食品药品监督管理局(FDA)、国际辐射防护委员会(ICRP)、美国能源部(DOE)等已建立辐射防护标准,认可此外,这些部门还制定了多项批准医疗辐射识别、监测和安全产品的协议。然而,这些严格的规定延长了产品批准过程。因此,严格的安全法规可能会延迟产品的推出和开发,预计会阻碍市场扩张。
按类型展望
医用辐射探测器市场按类型分为充气探测器、闪烁探测器和半导体探测器。到 2022 年,半导体部门在医用辐射探测器市场中占据相当大的收入份额。可以使用半导体检测器检测电离辐射。半导体检测器非常有效,因为它们可以将很大一部分入射辐射转换为电信号。因此,即使是非常低的辐射水平也可以被准确检测到。例如,美国核管理委员会声称固态探测器在识别低能伽马射线方面优于充气探测器。
产品前景
按产品划分,医用辐射检测器市场分为个人剂量计、过程剂量计、表面污染监测器等。到 2022 年,个人剂量计部分在医用辐射检测仪市场中占据最大的收入份额。个人剂量计因其便携性和易用性而变得越来越流行。在辐射暴露令人担忧的地区工作的工人使用个人剂量计监测他们的暴露水平。
最终用途展望
医用辐射探测器市场按最终用途细分为医院、门诊手术中心、诊断成像中心和家庭护理。2022 年医用辐射检测仪市场将占医院部分最大的收入份额。对 CT 扫瞄、X 射线和 PET 扫瞄等医学成像的需求不断增长。这是由于人口老龄化和慢性病的增加。医用辐射探测器在这些任务中非常重要,可确保患者接受适量的辐射并防止过度暴露。
区域展望
按地区划分,分析了北美、欧洲、亚太地区和 LAMEA 的医用辐射探测器市场。到 2022 年,北美地区将以最高的收入份额引领医用辐射检测仪市场。这是由于人们越来越担心在治疗过程中暴露于电离辐射可能带来的危险。因此,辐射安全越来越受到监管和医疗机构的关注。因此,越来越需要医用辐射探测器来正确测量辐射水平并提高患者安全。
The Global Medical Radiation Detection Market size is expected to reach $1.5 billion by 2029, rising at a market growth of 7.7% CAGR during the forecast period.
A medical device that finds radiation is called a medical radiation detector. An individual is more likely to develop several lethal diseases when exposed to radiation over a long period. The need for technology that can gauge how much radiation is building up inside the body grows. The radiation portal monitor (RPM), handheld survey meter (HSM), personal radiation detector (PRD), and radiation isotope identification device (RIID) are a few of the important detectors for spotting radioactive materials and ionizing radiation.
As technology develops, a variety of radiation-detecting tools might be made accessible for use at home. Gamma rays are the most hazardous external radioactive threat, and dosimeters are medical radiation detectors that can find them. Radiation in various forms is utilized for both medical diagnosis and treatment. However, exposure must be carefully managed to ensure that the benefits to patients outweigh the hazards because all types have the potential to be hazardous.
Radiation monitoring technology is in greater demand as more nuclear power plants are built worldwide. These power plants' byproducts can be applied to the healthcare sector. Hospitals also support the building of diagnostic imaging equipment by using medicinal isotopes supplied to patients.
The majority of the dose a person receives from man-made radiation sources comes from X-ray diagnostics and therapies using radioisotopes in oncology and some other critical disorders. Additionally being used are the future radioactive element-based diagnostic and treatment techniques. Radiation (radioisotope) therapy is still one of the main methods used to treat cancer. Market vendors are supplying personal dosimeters and automated systems for personal dosage control to lessen the harmful effects of radiation on the staff of healthcare facilities. Manufacturers and researchers are incorporating innovative technology into their goods to maintain their position as market leaders.
COVID-19 Impact Analysis
The pandemic has changed how diagnostic imaging tests are carried out. Numerous healthcare facilities have implemented new policies to lower the danger of COVID-19 transmission, like adopting portable X-ray machines and reducing the number of healthcare staff in the room while imaging is done. These alterations have increased the demand for mobile and handheld medical radiation detection tools that can be applied in various circumstances. In light of these elements, the medical radiation detection market has significantly benefited from the widespread of COVID-19.
Market Growth Factors
Rising cases of cancer across the globe
The treatment, detection, and prevention of different cancers have made significant strides in recent years. Cancer is treated using surgery, chemotherapy, radiation, and biological and hormonal therapy. Doxorubicin is a frequently prescribed chemotherapy medication that is used to treat several tumor types. Oxidative stress has an impact on the kidney, heart, and brain. Chemotherapy drug resistance in metastatic breast cancer is still a problem for effective treatment. As a result, this element is fueling the medical radiation detection market.
Growing utilization of radiation therapy and nuclear medicine
Instrumentation, and IT, nuclear medicine procedures have drastically changed over the past ten years. The need for radiation detection, monitoring, and safety systems has increased due to the growing use of nuclear medicine in diagnosing and treating many diseases, including cancer and cardiovascular ailments. Gas-filled detectors, scintillation detectors, and semiconductor detectors are the different types used in nuclear medicine. In light of these factors, the growing usage of radiation therapy and nuclear medicine is predicted to support the market expansion.
Market Restraining Factors
Strict regulatory mandates
The Nuclear Regulatory Commission (NRC), National Council on Radiation Protection (NCRP), Food and Drug Administration (FDA), International Commission on Radiological Protection (ICRP), and the US Department of Energy (DOE) have established radiation protection standards that are recognized by the national authorities. In addition, these departments have established multiple protocols to approve medical radiation identification, monitoring, and safety products. Nevertheless, these rigorous regulations prolong the duration of the product approval procedure. Hence, with the strict safety regulations which can delay product launches and development are expected to hamper the market expansion.
Type Outlook
Based on type, the medical radiation detection market is characterized into gas-filled detectors, scintillators, and solid-state. The solid-state segment covered a considerable revenue share in the medical radiation detection market in 2022. Ionizing radiation can be found using solid-state detectors, which are quite effective since they can turn a significant part of incident radiation into an electrical signal. They can accurately detect radiation at very low levels due to this. For instance, the U.S. Nuclear Regulatory Commission asserts that solid-state detectors are superior to gas-filled detectors at identifying low-energy gamma rays.
Product Outlook
On the basis of product, the medical radiation detection market is classified into personal dosimeters, area process dosimeters, surface contamination monitors, and others. In 2022, the personal dosimeters segment witnessed the largest revenue share in the medical radiation detection market. Because of its qualities, including being portable and simple to use, personal dosimeters are growing in popularity. Workers working in areas where radiation exposure poses a concern have their exposure levels monitored by personal dosimeters.
End-Use Outlook
By end-use, the medical radiation detection market is divided into hospitals, ambulatory surgical centers, diagnostic imaging centers, and homecare. In 2022, the hospitals segment dominated the medical radiation detection market with the maximum revenue share. There is a rising need for medical imaging treatments like CT scans, X-rays, and PET scans. This is due to the growing elderly population and the rise in chronic diseases. Medical radiation detectors are crucial in these operations to ensure patients receive the proper dose of radiation and to guard against overexposure.
Regional Outlook
Region wise, the medical radiation detection market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the medical radiation detection market by generating the highest revenue share. This can be due to rising anxiety around the dangers that could be involved with being exposed to ionizing radiation during medical treatments. As a result, radiation safety is receiving increased attention from regulatory agencies and medical establishments. This has increased the need for medical radiation detectors to measure radiation levels correctly and improve patient safety.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBA Dosimetry GmbH, Mirion Technologies, Inc., Thermo Fisher Scientific, Inc., LANDAUER (Fortive Corporation), Polimaster Europe UAB, PTW Freiburg GmbH, ATOMTEX, Radiation Detection Company, MP Biomedicals, LLC (Valiant Co. Ltd), and Amray Group Ltd.
Strategies Deployed in Medical Radiation Detection Market
2023-Mar: Polimaster announced the launch of the new Polismart iOS app for iPhones and iPads. The launch aims to build a smarter way for the innovative operation of Polimaster products. The product is designed to offer users radiation exposure analytics and deeper insights.
2023-Feb: Mirion Technologies, Inc. collaborated with Flyability, a provider of Indoor drone solutions. Under this collaboration, the Mirion RDS-32 radiation survey meter would be combined with Flyability's Elios 3 indoor drone. This combination would allow nuclear operators to collect accurate radiation data remotely by drone, enabling nuclear personnel to stay safely outside of irradiated areas at the time of data collection.
2022-Sep: IBA S.A. collaborated with ScandiDos A.B., a technology company engaged in advanced Radiation Therapy Quality Assurance for radiation therapy dosimetry solutions. The alliance would allow the two businesses to operate together on product development, marketing, and product distribution in the specified markets for patient quality assurance for radiotherapy.
2022-May: IBA completed the acquisition of Modus Medical Devices Inc., a company specializing in phantoms for quality assurance for radiation therapy. This acquisition strengthens IBA's Dosimetry operations across North America and adds complete dosimetry 'phantom' suite on the market.
2021-Dec: Mirion Technologies, Inc. completed the acquisition of Computerized Imaging Reference Systems, Inc., a provider of medical imaging and radiation therapy phantoms serving the medical industry. The acquisition enhances patient outcomes and expands Mirion's Medical Segment.
2021-Nov: Mirion Technologies, Inc. took over CHP Dosimetry, a distributor of Dosimetry services. With this acquisition, Mirion would directly serve CHP Dosimetry's existing customers that would continue to utilize Mirion's strong dosimetry products.
2021-Oct: Mirion Technologies, Inc. acquired the Dosimetry Badge brand, a distributor of personal dosimeter badges. Following this acquisition, Mirion would strengthen its place in the US dosimetry market and serve existing Dosimetry Badge customers while offering them the choice to explore strong dosimetry options.
2021-Oct: IBA partnered with TRAD Tests & Radiations, a company offering a high level of service for all radiation testing, calculation, and analysis services. This partnership would allow the development of the latest radiation processing module based on TRAD's RayXpert 3D modeling and dose calculation technology.
2019-Mar: Thermo Fisher Scientific introduced Thermo Scientific Harshaw thermoluminescence dosimeter, a new dosimetry monitoring service. This launch allows medical and imaging facilities, laboratories, dental offices, and nuclear power plants. The products are created to allow facility operators to observe and track individual employees accumulated radiation dose with accuracy and precision.
Market Segments covered in the Report:
By Product
By Type
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures